HUM
42
8
JBHT
63
3
SO
51
3
HRB
42
-2
XEL
39
2
GOOG
55
-12
XOM
44
-4
VNO
50
-2
ALL
54
-6
FOX
64
2
CAT
66
2
DLTR
62
-4
DE
43
-3
NOV
48
-4
ORCL
26
2
PM
47
-2
VZ
37
-5
A
48
8
MO
51
-6
AZO
45
5
HUM
42
8
JBHT
63
3
SO
51
3
HRB
42
-2
XEL
39
2
GOOG
55
-12
XOM
44
-4
VNO
50
-2
ALL
54
-6
FOX
64
2
CAT
66
2
DLTR
62
-4
DE
43
-3
NOV
48
-4
ORCL
26
2
PM
47
-2
VZ
37
-5
A
48
8
MO
51
-6
AZO
45
5
Financhill
Back

iShares LifePath Target Date 2040 ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Buy
64

ITDD
iShares LifePath Target Date 2040 ETF

Last Price:
$35.99
Seasonality Move:
2.42%
Buy
80

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.73
Seasonality Move:
11.35%
Buy
64
iShares LifePath Target Date 2040 ETF (ITDD) is a Buy

Is iShares LifePath Target Date 2040 ETF a Buy, Sell or Hold?

  • The current iShares LifePath Target Date 2040 ETF [ITDD] share price is $35.57. The Score for ITDD is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • ITDD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.80. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ITDD Stock Price Chart

What is iShares LifePath Target Date 2040 ETF's stock price today?

  • The iShares LifePath Target Date 2040 ETF share price today is $35.57
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITDD is experiencing slight buying pressure.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ITDD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.08 Buy
Relative Strength Index (14 RSI): 51.71 Buy
Chaikin Money Flow: -10404 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.77 Buy
Relative Strength Index (14 RSI): 85.1 Buy
Chaikin Money Flow: 991653 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (219.01 - 220.61) Buy
Bollinger Bands (100): (55.63 - 178.69) Buy

ITDD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.66 Sell
20-day SMA: 35.51 Buy
50-day SMA: 35.4 Buy
200-day SMA: 33.15 Buy
8-day EMA: 35.6 Sell
20-day EMA: 35.55 Buy
50-day EMA: 35.32 Buy
200-day EMA: 33.65 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.26 Buy
20-day SMA: 220.14 Buy
50-day SMA: 161.87 Buy
200-day SMA: 73.76 Buy
8-day EMA: 220.14 Buy
20-day EMA: 210.53 Buy
50-day EMA: 173.33 Buy
200-day EMA: 94.53 Buy

iShares LifePath Target Date 2040 ETF Earnings Growth & ITDD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

iShares LifePath Target Date 2040 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):